Tag: Burkitt-like lymphoma

Home / Burkitt-like lymphoma

Categories

Rituximab plus chemotherapy is approved by FDA for pediatric cancer indications

March 2022: The Food and Drug Administration has approved rituximab (Rituxan, Genentech, Inc.) in conjunction with chemotherapy for CD20-positive diffuse large B-cell lymphoma (DLBCL), Burkitt lympho...
burkitt-like-lymphoma

Scan the code